TerrAscendTSNDF +2.79%32 PB Ratio is 2.26 as of Jun. 25, 2026, which is 2% below its 10-year median of 2.31. GuruFocus rates TSNDF with a GF Score™ of 32/100 and a GF Value™ of $0.99 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 922 Drug Manufacturers companies, TerrAscend ranks worse than 58.13% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-06-25), TerrAscend's share price is $0.645. TerrAscend's Book Value per Share for the quarter that ended in Mar. 2026 was $0.29. Hence, TerrAscend's PB Ratio of today is 2.26.
The historical rank and industry rank for TerrAscend's PB Ratio or its related term are showing as below:
TSNDF'
s PB Ratio Range Over the Past 10 Years
Min: 0.41 Med: 2.31 Max: 19.65
Current: 2.22
During the past 10 years, TerrAscend's highest PB Ratio was 19.65. The lowest was 0.41. And the median was 2.31.
TSNDF's PB Ratio is ranked worse than 58.13% of 922
companies
in the Drug Manufacturers industry
Industry Median: 1.88
vs TSNDF: 2.22
During the past 12 months, TerrAscend's average Book Value Per Share Growth Rate was -51.60% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -34.20% per year.
During the past 10 years, the highest 3-Year average Book Value Per Share Growth Rate of TerrAscend was 83.10% per year. The lowest was -34.20% per year. And the median was 15.80% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
TerrAscend PB Ratio Related Terms
TerrAscend PB Ratio Historical Data
* Premium members only.
The historical data trend for TerrAscend's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, TerrAscend's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TerrAscend PB Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, TerrAscend's PB Ratio distribution charts can be found below:
* The bar in red indicates where TerrAscend's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
TerrAscend's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
TerrAscend (TSNDF) has a PB Ratio of 2.26 as of Jun. 25, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on TerrAscend and its competitors. This is near median its historical median of 2.31. Over the past decade, TerrAscend's PB Ratio has ranged from 0.41 to 19.65. According to the industry distribution chart, TerrAscend ranks #536 out of 922 companies in the Drug Manufacturers industry, placing it in the top 58.1%.
Is TerrAscend's PB Ratio too high?
TerrAscend's current PB Ratio of 2.26 is near median its 10-year median of 2.31. Over the past 10 years, this metric has ranged from a low of 0.41 to a high of 19.65. The Drug Manufacturers industry median PB Ratio is 1.88. TerrAscend's value of 2.26 is 20.2% above this industry median. Based on the distribution chart, TerrAscend ranks #536 out of 922 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, TerrAscend has a GF Score™ of 32/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does TerrAscend's PB Ratio compare to ZTS?
According to the Drug Manufacturers industry distribution chart, TerrAscend ranks #536 out of 922 companies for PB Ratio. This places TerrAscend in the lower half of its industry. The industry median PB Ratio is 1.88. TerrAscend's value of 2.26 is 20.2% above this benchmark. Historically, TerrAscend's own PB Ratio has ranged from 0.41 to 19.65 over the past decade. While the company's 10-year median is 2.31 vs. the industry median of 1.88, TerrAscend has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 1.88, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. TerrAscend's current PB Ratio of 2.26 is 20.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on TerrAscend and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 1.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TerrAscend's current PB Ratio is 2.26, which is near median its own 10-year median of 2.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TerrAscend stock overvalued right now?
Based on GuruFocus' analysis, TerrAscend (TSNDF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.99, compared to a current price of $0.65 — trading 34.8% below its estimated fair value. The current PB Ratio is 2.26, which is near median its 10-year median of 2.31 and 20.2% above the Drug Manufacturers industry median of 1.88. TerrAscend's overall GF Score™ is 32/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For TerrAscend (TSNDF), the current PB Ratio is 2.26 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is TerrAscend (TSNDF) Overvalued in 2026?
Based on GuruFocus' analysis, TerrAscend stock appears to be undervalued.
The current stock price of $0.65 is trading 34.8% below its estimated GF Value™ of $0.99.
GuruFocus considers TerrAscend to be Possible Value Trap.
Key valuation signals for TSNDF:
PB Ratio: 2.26 (near median its 10-year median of 2.31)
GF Value™: $0.99 vs. price of $0.65 (34.8% below fair value)
Industry Position: 20.2% above the Drug Manufacturers median (#536 of 922)
No single metric tells the full story. See the TSNDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
TerrAscend Corp is a company focused on creating and delivering cannabis products and services that meet the evolving needs of its patients. It also provides education and support programs to physicians and patients through healthcare professionals. In addition, the firm operates in California, Maryland, New Jersey, and Pennsylvania, with retail operations in Ohio and Canada. It operates The Apothecarium and other dispensary retail locations as well as scaled cultivation, processing, and manufacturing facilities in its core markets. The firm has one operating segment, being the cultivation, production, and sale of cannabis products, with subsidiaries located in Canada and the United States. The company generates key revenue from the United States.
32GF Score
Get the complete analysis for TSNDF
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSNDF has been successfully added to your 
